Identification of MPL W515L/K Mutations in Patients with Primary Myelofibrosis and Essential Thrombocythaemia by Allele-Specific Polymerase Chain Reaction

被引：5

作者：

Daly, Sarah ^{[1
]}

Conneally, Eibhlin ^{[1
]}

Langabeer, Stephen E. ^{[1
]}

机构：

[1] St James Hosp, Cent Pathol Lab, Dept Haematol, Dublin 8, Ireland

来源：

ACTA HAEMATOLOGICA | 2009年 / 121卷 / 04期

关键词：

MYELOPROLIFERATIVE DISORDERS; JAK2;

D O I：

10.1159/000224333

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：221 / 222

页数：2

共 8 条

[1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].

Baxter, EJ ;

Scott, LM ;

Campbell, PJ ;

East, C ;

Fourouclas, N ;

Swanton, S ;

Vassiliou, GS ;

Bench, AJ ;

Boyd, EM ;

Curtin, N ;

Scott, MA ;

Erber, WN ;

Green, AR .

LANCET, 2005, 365 (9464) :1054-1061

[2] MPL mutations in myeloproliferative disorders:: analysis of the PT-1 cohort [J].

Beer, Philip A. ;

Campbell, Peter J. ;

Scott, Linda M. ;

Bench, Anthony J. ;

Erber, Wendy N. ;

Bareford, David ;

Wilkins, Bridget S. ;

Reilly, John T. ;

Hasselbalch, Hans C. ;

Bowman, Richard ;

Wheatley, Keith ;

Buck, Georgina ;

Harrison, Claire N. ;

Green, Anthony R. .

BLOOD, 2008, 112 (01) :141-149

[3] Anaemia characterises patients with myelofibrosis harbouring MplW515L/K mutation [J].

Guglielmelli, Paola ;

Pancrazzi, Alessandro ;

Bergamaschi, Gaetano ;

Rosti, Vittorio ;

Villani, Laura ;

Antonioli, Elisabetta ;

Bosi, Alberto ;

Barosi, Giovanni ;

Vannucchi, Alessandro M. .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (03) :244-247

[4] Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders [J].

Levine, Ross L. ;

Pardanani, Animesh ;

Tefferi, Ayalew ;

Gilliland, D. Gary .

NATURE REVIEWS CANCER, 2007, 7 (09) :673-683

[5] TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations [J].

Pardanani, A. ;

Hood, J. ;

Lasho, T. ;

Levine, R. L. ;

Martin, M. B. ;

Noronha, G. ;

Finke, C. ;

Mak, C. C. ;

Mesa, R. ;

Zhu, H. ;

Soll, R. ;

Gilliland, D. G. ;

Tefferi, A. .

LEUKEMIA, 2007, 21 (08) :1658-1668

[6] MPL515 mutations in myeloproliferative and other myeloid disorders:: a study of 1182 patients [J].

Pardanani, Animesh D. ;

Levine, Ross L. ;

Lasho, Terra ;

Pikman, Yana ;

Mesa, Ruben A. ;

Wadleigh, Martha ;

Steensma, David P. ;

Elliott, Michelle A. ;

Wolanskyj, Alexandra R. ;

Hogan, William J. ;

McClure, Rebecca F. ;

Litzow, Mark R. ;

Gilliland, D. Gary ;

Tefferi, Ayalew .

BLOOD, 2006, 108 (10) :3472-3476

[7] MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia [J].

Pikman, Yana ;

Lee, Benjamin H. ;

Mercher, Thomas ;

McDowell, Elizabeth ;

Ebert, Benjamin L. ;

Gozo, Maricel ;

Cuker, Adam ;

Wernig, Gerlinde ;

Moore, Sandra ;

Galinsky, Ilene ;

DeAngelo, Daniel J. ;

Clark, Jennifer J. ;

Lee, Stephanie J. ;

Golub, Todd R. ;

Wadleigh, Martha ;

Gilliland, D. Gary ;

Levine, Ross L. .

PLOS MEDICINE, 2006, 3 (07) :1140-1151

[8] Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia [J].

Vannucchi, Alessandro M. ;

Antonioli, Elisabetta ;

Guglielmelli, Paola ;

Pancrazzi, Alessandro ;

Guerini, Vittoria ;

Barosi, Giovanni ;

Ruggeri, Marco ;

Specchia, Giorgina ;

Lo-Coco, Francesco ;

Delaini, Federica ;

Villani, Laura ;

Finotto, Silvia ;

Ammatuna, Emanuele ;

Alterini, Renato ;

Carrai, Valentina ;

Capaccioli, Gloria ;

Di Lollo, Simonetta ;

Liso, Vincenzo ;

Rambaldi, Alessandro ;

Bosi, Alberto ;

Barbui, Tiziano .

BLOOD, 2008, 112 (03) :844-847

← 1 →